-
Electronic (PDF)
-
Electronic (Online Access)
-
Enterprisewide
-
Enterprisewide
The Medical Device Market: Poland
Espicom Business Intelligence Ltd, April 2013, Pages: 76
Espicom’s in-depth medical device market reports are ideal for executives wanting to understand the key drivers in medical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
The Republic of Poland is bordered by Russia (Kaliningrad), Lithuania, Belarus, Ukraine, Germany, the Czech Republic and Slovakia. It was one of the ten countries to join the EU in May 2004. The Polish population stands at 38.1 million in 2012. Around 13.9% of residents are aged 65 years or over.
Funding for healthcare in Poland is principally through the health insurance system. The National Health Fund was established in 2003, replacing the 16 Regional Health Funds. Financing remains a problem, although Poland has boosted spending levels since 2004. It now spends around 7.5% of GDP on healthcare. This still does not fully cover the cost of medical equipment and upgrades required in hospitals.
The size of the private healthcare sector is slowly expanding. The availability of private facilities improved significantly in 2000, when bed numbers increased three-fold. Around a quarter of health expenditure is private, although out-of-pocket payments account for most of this.
In 2012, the Polish market for medical equipment and supplies is estimated at US$2,219.2 million, or US$58 per capita. The market experienced rapid growth until 2009 when imports fell back sharply. The economic downturn has so far proved short, however, with growth resuming in 2010 and throughout 2011, albeit at a slightly lower rate than in previous years.
Around 85% of the medical device market is supplied by imports. Germany and the Netherlands were the leading suppliers in 2011, together accounting for around nearly half of imports. Germany was the leading supplier of most categories of medical equipment.
PROVIDING STRATEGIC MARKET ANALYSIS EVERY MONTH
These highly-regarded world medical technology and device market research reports provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the medical equipment market in context. The reports provide:
Unique projected estimates of market size and growth for 33 equipment categories
Five year statistical data for key economic and healthcare indicators
Information on regulation, distribution and market access, including Espicom’s unique distributor directory
Detailed Medical trade data
Data on leading local/multinational medical equipment players in the market
MAKING YOUR MARKET RESEARCH INVESTMENT WORK WITH POWERFUL ONLINE TOOLS
At no additional cost, all customers get access to Espicom Interactive. This advanced online service is easy-to-use and contains practical and valuable tools which will save you hours of time and effort.
Full text cross file searching with fast response or intuitive “drill down” into the content
Presentation-ready tables and graphics with “one click” output to other packages such as MS Excel™ and MS PowerPoint™
View all tables and graphs independently from the text
Split screen for more efficient working
Instant machine translation into nine languages
A “Cut your own” report building feature
Pdf download
This report is also delivered in your choice of pdf or print formats
WITH THIS MARKET REPORT YOU CAN
Evaluate the potential of the market
Assess risks and opportunities on the basis of knowledge
Profile the market for new product, licences or collaborations
Understand the operating and regulatory environment
Gain a complete picture on health expenditure and infrastructure
Review the competitive environment
EXECUTIVE SUMMARY
Introduction
Pharmaceutical Market Analysis
Size
Market Structure
Generics Sector
OTC Sector
Projections & Outlook
Imports
Domestic Manufacturing
Domestic Production
Structural changes
Biotechnology Industry
Trade Association(s)
Local Manufacturers
Adamed Ltd.
Bioton S.A.
Jelfa SA
Lek Polska
Molteni Farmaceutici Polska
Pliva Kraków
Polfa Grodzisk
Polfa Kutno
Polfa Lódz
Polfa Lublin
Polfa Pabianice
Polfa Rzeszów
Polfa Tarchomin
Polfa Warzsawa
Polpharma
Multinational Manufacturers
Eli Lilly
GlaxoSmithKline Poznan
Nycomed (formerly Altana Pharma and Polfa Lyszkowice)
Sanofi-Aventis
Exports
Research & Development
Pharmaceutical Regulatory Analysis
Pharmaceutical Regulation
Advertising
Pricing & Reimbursement
Intellectual Property
Pharmaceutical Distribution
Wholesaling
ACP Pharma (formally ORFE)
Cefarm
Phoenix Pharma Polska
Polska Grupa Farmaceutyczna (PGF)
Retailing
Online pharmacies
Healthcare Analysis
Demographics
Population
Birth Rate
Death Rate
Infant Mortality
Life Expectancy at Birth
Public Health
Causes of Death
Incidence of Communicable Disease
Incidence of Non-Communicable Disease
HIV/AIDS
National Programme for Combating AIDS and Preventing HIV Infections for the Years 2007-2011
Healthcare System
Health Expenditure
Healthcare Infrastructure
Inpatient Analysis
Healthcare Personnel
DIRECTORY
Government Organisations
Trade Associations
Methodology & Sources
List of Tables
Summary of Key Data Projections, 2008-2013
Summary of the Polish Pharmaceutical Market, 2008
Market Projections, 2008-2013
SWOT Analysis of the Polish Pharmaceutical Market, 2008
Imports of Pharmaceuticals by Category, 2002-2006 (US$000s)
Import Trends
Leading Suppliers of Raw Materials, 2006 (US$000s)
Leading Suppliers of Medicaments, 2006 (US$000s)
Parallel Imports
Polfa Group Since Privatisation
Bioton S.A. Financial Results, 2005-2007 (000s)
Exports of Pharmaceuticals, 2002-2006 (US$000s)
Export Trends
Leading Destinations, 2006 (US$000s)
Pharmacies and Pharmaceutical Outlets, 1995-2007
Summary of Demographic Data, 2006/7
Projected Population, 2008-2013
Projected Health Expenditure, 2008-2013
Hospitals & Beds, 2006
Hospital Bed Projections, 2008-2013
General Hospital Activity by Speciality, 1994-2001
Projected Number of Physicians, 2008-2013
- Aesculap-Chifa Sp. z.o.o.
- Asonik
- Balton Ltd
- Chirmed-Vamag
- Emtel
- ERG Klobuck S.A
- Famed Ltd.
- Farum S.A
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
